Acessibilidade / Reportar erro

Two fast screening methods (GC-MS and TLC-ChEI assay) for rapid evaluation of potential anticholinesterasic indole alkaloids in complex mixtures

Abstracts

The pharmacotherapyfor Alzheimer's disease (AD) includes the use of acetylcholinesterase inhibitors (AChEI). Recent investigations for novel AD therapeutic agents from plants suggested that Tabernaemontana genus is a promising source of novel anticholinesterasic indole alkaloids. In this work two fast screening techniques were combined in order to easily identify novel cholinesterase inhibitors (ChEI). Gas chromatography-mass spectrometry (GC-MS) of the less polar alkaloidic fractions obtained from the acid-base extraction of the stalk of T. laeta revealed thirteen monoindole alkaloids, four of them confirmed by co-injection with previously isolated alkaloids. The others were tentatively identified by mass fragmentation analysis. By gas chromatography with flame ionization detection (GC-FID) and using isatin as internal standard, affinisine and voachalotine were determined as major compounds. These fractions and fourteen previously isolated alkaloids, obtained from root bark of T. laeta and T. hystrix were investigated for acetyl (AChE) and butyrylcholinesterase (BuChE) inhibitory activities by the modified Ellman's method in thin layer chromatography(TLC-ChEI). Results showed selective inhibition of the alkaloids heyneanine and Nb-methylvoachalotine for BuChE, and 19-epi-isovoacristine for AChE, whereas olivacine, affinisine, ibogamine, affinine, conodurine and hystrixnineinhibited both enzymes. In addition to confirming that monoterpenoid indole alkaloids can be novel therapeutic agents for AD, this is the first report of the ChEI activity of olivacine, a pyridocarbazole alkaloid.

Tabernaemontana; indole alkaloids; cholinesterase inhibitor; thin-layer chromatography assay; Ellman´s method; GC-MS


Dentre os tratamentos da doença de Alzheimer (DA) está o uso de inibidores da enzima acetilcolinesterase. Pesquisas recentes visando a descoberta de novos agentes terapêuticos naturais para esta doença sugerem que o gênero Tabernaemontana é uma fonte promissora de alcalóides indólicos anticolinesterásicos. Neste trabalho, duas técnicas de análise em mistura foram associadas de modo a identificar facilmente novos inibidores colinesterásicos. A cromatografia em fase gasosa acoplada a espectrometria de massas (CG-EM) das frações alcaloídicas apolares, obtidas da extração ácido-base do caule de T. laeta, revelou a presença de treze alcalóides monoindólicos, quatro deles confirmados por co-injeção com padrões previamente isolados. Os outros alcalóides foram tentativamente identificados pelo padrão de fragmentação de massas. Por cromatografia em fase gasosa com detecção por ionização de chama (CG-DIC) e utilizando isatina como padrão interno, affinisina e voachalotina foram identificadas como substâncias majoritárias. As frações alcaloídicas obtidas e os quatorze alcalóides previamente isolados das raízes de T. laeta e T. hystrix foram analisados quanto à atividade inibitória das enzimas acetil (AChE) e butirilcolinesterase (BuChE) pelo método de Ellman em cromatografia em camada delgada (CCD-ChEI). Os resultados revelaram uma inibição seletiva dos alcalóides heyneanina e Nb-metilvoachalotina para BuChE e de 19-epi-isovoacristina para AChE, enquanto que olivacina, affinisina, ibogamina, affinina, conodurina e hystrixnina inibiram ambas as enzimas. Além de confirmar que alcalóides indólicos monoterpênicos são agentes terapêuticos promissores para o tratamento da DA, este é o primeiro relato da atividade anticolinesterásica de olivacina, um alcalóide piridocarbazólico.

Tabernaemontana; alcalóides indólicos; inibidor colinesterásico; cromatografia em camada delgada; método de Ellman; CG-EM


CHEMICAL SCIENCES

Two fast screening methods (GC-MS and TLC-ChEI assay) for rapid evaluation of potential anticholinesterasic indole alkaloids in complex mixtures

Ivo J.C. VieiraI; Walter L.B. MedeirosI; Cecilia S. MonneratI; Jucimar J. SouzaI; Leda MathiasI; Raimundo Braz-FilhoI; Angelo C. PintoII; Priscila M. SousaII; Claudia M. RezendeII; Rosângela De A. EpifanioIII

ILaboratório de Ciências Químicas, Centro de Ciência e Tecnologia, Universidade Estadual do Norte Fluminense Darcy Ribeiro, Av. Alberto Lamego, 2000, Parque Califórnia, 28013-600 Campos dos Goytacazes, RJ, Brasil

IIDepartamento de Química Orgânica, Instituto de Química, Universidade Federal do Rio de Janeiro, Centro de Tecnologia, Bloco A, Cidade Universitária, Ilha do Fundão, 21945-970 Rio de Janeiro, RJ, Brasil

IIIDepartamento de Química Orgânica, Instituto de Química, Universidade Federal Fluminense, Outeiro de São João Batista s/n, Centro, 24020-141 Niterói, RJ, Brasil

Correspondence to Correspondence to: Rosângela de A . Epifanio E-mail: rosangela@rmn.uff.br

ABSTRACT

The pharmacotherapyfor Alzheimer's disease (AD) includes the use of acetylcholinesterase inhibitors (AChEI). Recent investigations for novel AD therapeutic agents from plants suggested that Tabernaemontana genus is a promising source of novel anticholinesterasic indole alkaloids. In this work two fast screening techniques were combined in order to easily identify novel cholinesterase inhibitors (ChEI). Gas chromatography-mass spectrometry (GC-MS) of the less polar alkaloidic fractions obtained from the acid-base extraction of the stalk of T. laeta revealed thirteen monoindole alkaloids, four of them confirmed by co-injection with previously isolated alkaloids. The others were tentatively identified by mass fragmentation analysis. By gas chromatography with flame ionization detection (GC-FID) and using isatin as internal standard, affinisine and voachalotine were determined as major compounds. These fractions and fourteen previously isolated alkaloids, obtained from root bark of T. laeta and T. hystrix were investigated for acetyl (AChE) and butyrylcholinesterase (BuChE) inhibitory activities by the modified Ellman's method in thin layer chromatography(TLC-ChEI). Results showed selective inhibition of the alkaloids heyneanine and Nb-methylvoachalotine for BuChE, and 19-epi-isovoacristine for AChE, whereas olivacine, affinisine, ibogamine, affinine, conodurine and hystrixnineinhibited both enzymes. In addition to confirming that monoterpenoid indole alkaloids can be novel therapeutic agents for AD, this is the first report of the ChEI activity of olivacine, a pyridocarbazole alkaloid.

Key words:Tabernaemontana, indole alkaloids, cholinesterase inhibitor, thin-layer chromatography assay, Ellman´s method, GC-MS.

RESUMO

Dentre os tratamentos da doença de Alzheimer (DA) está o uso de inibidores da enzima acetilcolinesterase. Pesquisas recentes visando a descoberta de novos agentes terapêuticos naturais para esta doença sugerem que o gênero Tabernaemontana é uma fonte promissora de alcalóides indólicos anticolinesterásicos. Neste trabalho, duas técnicas de análise em mistura foram associadas de modo a identificar facilmente novos inibidores colinesterásicos. A cromatografia em fase gasosa acoplada a espectrometria de massas (CG-EM) das frações alcaloídicas apolares, obtidas da extração ácido-base do caule de T. laeta, revelou a presença de treze alcalóides monoindólicos, quatro deles confirmados por co-injeção com padrões previamente isolados. Os outros alcalóides foram tentativamente identificados pelo padrão de fragmentação de massas. Por cromatografia em fase gasosa com detecção por ionização de chama (CG-DIC) e utilizando isatina como padrão interno, affinisina e voachalotina foram identificadas como substâncias majoritárias. As frações alcaloídicas obtidas e os quatorze alcalóides previamente isolados das raízes de T. laeta e T. hystrix foram analisados quanto à atividade inibitória das enzimas acetil (AChE) e butirilcolinesterase (BuChE) pelo método de Ellman em cromatografia em camada delgada (CCD-ChEI). Os resultados revelaram uma inibição seletiva dos alcalóides heyneanina e Nb-metilvoachalotina para BuChE e de 19-epi-isovoacristina para AChE, enquanto que olivacina, affinisina, ibogamina, affinina, conodurina e hystrixnina inibiram ambas as enzimas. Além de confirmar que alcalóides indólicos monoterpênicos são agentes terapêuticos promissores para o tratamento da DA, este é o primeiro relato da atividade anticolinesterásica de olivacina, um alcalóide piridocarbazólico.

Palavras-chave:Tabernaemontana, alcalóides indólicos,inibidor colinesterásico, cromatografia em camada delgada, método de Ellman, CG-EM

INTRODUCTION

The year 2006 marked a century since the first description of Alzheimer's disease (AD) by Alois Alzheimer. AD, considered the most common neurodegenerative disease that affects the elderly, is characterized by progressive memory loss, decline in language skills and other serious cognitive impairments (Goedert and Spillantini 2006).

The etiology of AD is not very clear and multiple factors, such as amyloid-β peptide (Aβ) and tau protein aggregation, excessive transition metals, oxidative stress and reduced acetylcholine (ACh) level, have been implicated (Ji and Zhang 2006). However, it is a cholinergic deficiency rather than other neurochemical deficits that is thought to play a pivotal role in the development of AD symptoms (Farlow 2002). For this reason, inhibition of brain acetylcholinesterase (AChE) has been the major therapeutic target of AD treatment strategies.

Whereas several new natural and synthetic compounds are reported in the scientific literature as cholinesterase inhibitors (ChEI) candidates, this research is continuously improved as better drugs for AD is still required. Within the structure diversity of the ChEI, plant alkaloids are the most studied already leading to the development of new drugs (e.g. galanthamine, huperzine and phenserines) (Houghton et al. 2006, Mukherjee et al. 2007).

Monoterpenic indole alkaloids have been extensively investigated for exhibiting numerous biological activities (such as anti-tumor, anti-microbial, anti-hypertensive or as a central nervous system stimulant) (Andrade et al. 2005, Saxton 1997). They can be found in plants of the Apocynaceae, Rubiaceae, and Loganiaceae families and a few have recently been reported as ChEI by different research groups (Hostettmann et al. 2006). Among the AChEI found are some indole glucoalkaloids from Chimarrhis turbinate (Rubiaceae) (Cardoso et al. 2004); sarpagan type alkaloids from the Haplophyton crooksii (Apocynaceae) (Mroue et al. 1996); iboga alkaloids from Tabernaemontana australis (Apocynaceae) (Andrade et al. 2005) and vobasinyl-iboga bis-indolealkaloids from T. divaricata (Ingkaninan et al. 2006). In fact, a recent article reported the inhibition of cortical AChE activity and the enhancement of neuronal activity of T. divaricata extracts in rats, suggesting that it is a reversible AChE inhibitor and could be beneficial as a novel therapeutic agent for AD (Chattipakorn et al. 2007).

The genus Tabernaemontana (Apocynaceae) hasbeen used in traditional rejuvenation remedies, believed to improve memory, or central nervous system stimulant (Chattipakorn et al. 2007). It is especially rich in complex mixtures of monoterpenic indole alkaloids and several Brazilian native species have been chemically investigated being good candidates to furnish cholinesterase inhibitory compounds (Batina et al. 2000, Batista et al. 1996, Bolzani et al. 1984, Cardoso and Vilegas 1999, Cardoso et al. 1997, 1998, Henriques et al. 1996, Kato et al. 2002, Lemos et al. 1996, Marques et al. 1996, Medeiros et al. 1999, 2001, Monnerat et al. 2005, Pereira et al. 2004, Rattmann et al. 2005, Zocoler et al. 2005).

In this work we associated two fast screening techniques, a chemical screening by GC-MS and an enzymatic activity screening by Ellman's TLC assay (TLC-ChEI), supported by a collection of previously isolated monoindole alkaloids, in order to suggest a rapid evaluation of potential cholinesterase inhibitors alkaloids from Apocynaceae family.

MATERIALS AND METHODS

GENERAL EXPERIMENTAL PROCEDURES

Acetylcholinesterase (AChE) from electric eel (EC3117); acetylthiocoline iodide (ATCI); butyrylcholinesterase (BuChE) from horse serum (EC 3118); butyrylthiocoline chloride (BTCC); 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB); Trisma hydrochloride (Tris-HCl)buffer solution, pH 8.0; the reference compound physostigmine and thin layer chromatography (TLC) polyethylene sheets silica gel 60 F254, 0.2 mm thickness were purchased from Sigma (St. Louis, MO, USA).

GAS CHROMATOGRAPHY ANALYSES

Gas chromatography (GC) analyses were carried out on an Agilent GC 6890 gas chromatography (Palo Alto, USA) equipped with a fused silica DB1 (J&W, 30 m × 250 µm ×0.30 µm) capillary column directly coupled to a quadrupole mass spectrometer Agilent 5973. EI-mass spectra were recorded at 70eV. Conditions: injector (splitless mode) at 250°C; oven temperature: 150°C (6 min) to 300°C (20 min) at 4°C min and He as carrier gas at 1 mL min.Samples were analyzed by 1µL injection of 5 mg mL solutions in CHCl. Isatin (0.5 mg mL) was used as internal standard.

PLANT MATERIAL

The stalk of Tabernaemontana laeta Mart. was collected in July 2004 at the Botanical Garden of Rio de Janeiro, Rio de Janeiro State, Brazil. A voucher specimen is deposited at the herbarium of the same Institution under the number RB 342087.

EXTRACTION AND ISOLATION OF ALKALOIDS

Stalk of T. laeta (150 g) was dried at 25°C for 15 days, ground and extracted on a Soxhlet apparatus with EtOH for 72 h. After reduced pressure concentration, the average yield of samples extracted in triplicate was 1.46 g of a brown residue. Dried ethanolic extracts were suspended in 100 mL of 1% HCl and extracted with EtOAc and CHCl (3 ×30 mL each). The pH of the aqueous acidic fraction was adjusted to 3, 5, 7, 9 and 11 with aqueous NHOH, extracted with CHCl (3 ×30 mL) and dried over anhydrous NaSO. Triplicates of each pH extract were analyzed by silica gel TLC using CHCl: MeOH (9:1) as eluent and staining with 50% HSO/heat or Dragendorff's reagent. Under these conditions, fractions related to pH 7 and pH 9 were combined. After solvents evaporation under reduced pressure, concentration triplicate average yielded 14.5 mg (pH 3), 8.4 mg (pH 5), 17.5 mg (pH 7 and pH 9) and 3.9 mg (pH 11).

The alkaloids 1-17 (Table I) were previously isolated by the authors and the experimental procedures are described elsewhere (Andrade et al. 2005, Medeiros et al. 1999, 2001, Monnerat et al. 2005).

CHOLINESTERASE INHIBITORY ACTIVITY DETERMINATION (TLC-CHEI)

Acetylcholinesterase and butyrylcholinesterase inhibitory activity was determined using TLC assay method and staining with Ellman's reagent (DTNB), which follows the technique described by Rhee et al. (Rhee et al. 2001). Pure compounds (0.051 and 0.005 mol L), fractions (5 mg mL) or extracts (10 mg mL) were diluted in appropriate solvent, then 1.0µL of each sample was spotted on the silica gel TLC plates and developed with CHCl:MeOH; (95:5); 1.0µL of 0.36 mmol L physostigmine solution in methanol was also spotted as reference. After developing the TLC plate, enzyme inhibitory activities were detected by spraying the substrate, dye and enzyme. The presence of cholinesterase inhibitory activity was determined by the formation of well-defined white spots made visible by spraying with DTNB, which gives a yellow background. In these experiments the minimum amount (detection limit) of physostigmine that could be recognized as a positive result was 0.07 µg.

False-positive reactions were eliminated according to the method described by Rhee et al (Rhee et al. 2003). Briefly, 3 U mL AChE was incubated for 15 min at 37°C with 1 mmol L of ATCI in buffer solution and then used as the thiocoline spray reagent. The developed TLC sample spots together with the known false-positive p-anisaldehyde were analyzed by spraying the dye followed by the thiocholine solution. White spots, indicating false-positive reactions, on a yellow background were recorded, and then compared with the results of the enzymatic assays. Four TLC plates were processed as above for, respectively, AChE, BuChE, and false positive assays, or revealed under UV and with HSO 50% or Dragendorff's solutions before heating.

RESULTS AND DISCUSSION

GC-FID AND GC-MS ANALYSES

The stalk of Tabernaemontana laeta Mart. collected in July 2004 at the Botanical Garden of Rio de Janeiro, Rio de Janeiro State, Brazil, was extracted with ethanol and fractionated at five different pH (3, 5, 7, 9 and 11). Silica gel TLC of the fractions showed the presence of alkaloids after Dragendorff's reagent stain. The less polar fractions observed in TLC (pH 3 and 5) were chosen for GC-MS analysis. By standard co-injection with previously isolated alkaloids from Tabernaemontana spp. and tentative identification by mass fragmentation pattern, 13 monoterpenic indole alkaloids were identified (Table II and Fig. 1). GC-MS and GC-FID using isatin as internal standard showed affinisine (2) and voachalotine (23) as major compounds in both fractions. As shown in Table II, other minor alkaloids with iboga, voacanga and sarpagan skeletons were also identified.


All the structures showed in Figure 1 were based on the more recent literature data and CAS registries.

CHE INHIBITTION ACTIVITY BY MODIFIED ELLMAN'S METHOD IN TLC

Some of these alkaloids were previously isolated from T. australis crude extracts and exhibited AChE inhibitory activity [affinisine (2), coronaridine (5), voacangine ( 14) and voacangine hydroxyindolenine (15)] (Andrade et al. 2005), suggesting that a major investigation of this class of natural compounds would reveal interesting results. So, the fractions obtained from the stalk of T. laeta and a small collection of previously isolated alkaloids such as: conodurine (4), heyneanine (6), iboxygaine (9), isovoacangine (10), 19-epi-isovoacristine (11), voacamine (13), Nb-methyl voachalotine (16) and tabernamine (17)from root bark of T. laeta (Medeiros et al. 2001); affinine (1), affinisine (2), Nb-methyl affinisine (3), hystrixnine (7), ibogamine (8) and olivacine (12) from T. hystrix (Monnerat et al. 2005) were assayed by Ellman's TLC method for butyryl and acetylcholinesterase inhibitory activities (BuChEI and AChEI).

From the fractions of pH 3 and 5, four spots showed ChEI activity, three of them were associated to affinisine (2), ibogamine (8) and olivacine (12) andinhibited both enzymes. The last spot was associated with Nb-methyl voachalotine (16) and appears to beBuChE selective. Beside this, affinine (1), conodurine (4) and hystrixnine (7), also showed AChE and BuChE inhibitory activities, heyneanine (6) and Nb-methyl voachalotine (16) inhibited only BuChE and 19-epi-isovoacristine (11) appears to be AChE selective. From the alkaloids studied, only Nb-methyl affinisine (3), iboxygaine (9), isovoacangine (10), the bis-alkaloids voacamine (13) and tabernamine (17) did not inhibited either of the two enzymes in Elmann's TLC test.

The preliminary activity of the 17 alkaloids assayed in this work indicated that the structure-activity relationship of this class of compounds is complex and should be investigated in detail. Ingkaninan et al. suggested that substitutions at carbons 11', 12' and 16' affect the bis-indole alkaloids AChEI activity in Ellman's assay (Ingkaninan et al. 2006). Although we have to be careful with the preliminary results obtained by TLC assays, this property was not observed in the present work.

Besides the iboga, voacanga and tetrahydro β-carboline sarpagan alkaloids, olivacine (12) was the only pyridocarbazole assayed and showed to be an active substance at the smallest quantity used (0,051µmol). The indication of dual or selective inhibition of BuChE and AChE of some alkaloids also suggested that these compounds can be interesting models to study the biochemical interactions with cholinesterases as well as the pharmacological benefits of such selectivity.

CONCLUSIONS

GC-MS is a valuable tool to screen indole alkaloids such as those with iboga and sarpagan skeletons. These compounds frequently show intense molecular and characteristic diagnostic ions. Present investigation of the stalk of T. laeta revealed thirteen alkaloids by GC-MS, whereas only five have been previously described.

The combination of two techniques such as GC-MS and TLC-ChEI assay has led to a rapid chemical and biological screening of already known indole alkaloids. These results also confirm the AChE and BuChE inhibitory activities of monoterpenic indole alkaloids, and corroborate that TLC assay based on Ellman's method is simpler, fast and inexpensive method to search AChE and BuChE inhibitors from natural sources.

In addition, this is the first report of the ChEI activity of olivacine (12), a pyridocarbazole alkaloid.

ACKNOWLEDGMENTS

Financial support and fellowships from " Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro" (FAPERJ, Brazil), " Conselho Nacional de Desenvolvimento Científico e Tecnológico" (CNPq, Brazil) and " Coordenação de Aperfeiçoamento de Pessoal de Nível Superior" (CAPES, Brazil) are greatly appreciated. We also thank Dr. Bruno Rezende Maia (Botanical Garden of Rio de Janeiro) for the botanical identification and the student Meriane P. Carvalho for her help during some bioassays.

REFERENCES

ANDRADE MT, LIMA JA, PINTO AC, REZENDE CM, CARVALHO MP AND EPIFANIO R DE A. 2005. Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme. BioorgMed Chem 13: 4092–4095.

BATINA MD, CINTRA ACO, VERONESE ELG, LAVRADOR MAS, GIGLIO JR, PEREIRA PS, DIAS DA, FRANCA SC AND SAMPAIO SV. 2000. Inhibition of the lethal and myotoxic activities of Crotalus durissus terrificus venom by Tabernaemontana catharinensis: Identification of one BATof the active components. Planta Med 66: 424–428.

BATISTA CVF, SCHRIPSEMA J, VERPOORTE R, RECH SB AND HENRIQUES AT. 1996. Indole alkaloids from Rauwolfia sellowii. Phytochemistry 41: 969–973.

BOLZANI VS, DA ROCHA AI AND GOTTLIEB OR. 1984. Plant chemosystematics and phylogeny. 23. Indole alkaloids as systematic markers of the Apocynaceae. Biochem Syst Ecol 12: 159–166.

CARDOSO CAL AND VILEGAS W. 1999. Droplet countercurrent chromatography of indole alkaloids from Tabernaemontana hilariana. Phytochem Anal 10: 60–63.

CARDOSO CAL, VILEGAS W AND POZETTI GL. 1997. Gas chromatographic analysis of indole alkaloids from Tabernaemontana hilariana. J Chromatogr A 788: 204–206.

CARDOSO CAL, VILEGAS W AND HONDA NK. 1998. Qualitative determination of indole alkaloids, triterpenoids and steroid of Tabernaemontana hilariana. J Chromatogr A 808: 264–268.

CARDOSO CAL, CASTRO-GAMBOA I, SILVA DHS, FURLAN M, EPIFANIO R DE A, PINTO AC, REZENDE CM,LIMA JA AND BOLZANI VS. 2004. Indole glucoalkaloids from Chimarrhis turbinate and their evaluation as antioxidant agents and acetylcholinesterase inhibitors. J Nat Prod 67: 1882–1885.

CHATTIPAKORN S, PONGPANPARADORN A, PRATCHAYASAKUL W, PONGCHAIDACHA A, INGKANINAN K AND CHATTIPAKORN N. 2007. Tabernaemontana divaricata extract inhibits neuronal acetylcholinesterase activity in rats. J Ethnopharmacol 110: 61–68.

FARLOW M. 2002. A clinical overview of cholinesterase inhibitors in Alzheimer's disease. Int Psychogeriatr 14: 93–126.

GOEDERT M AND SPILLANTINI MG. 2006. A century of Alzheimer's disease. Science 314: 777–781. HENRIQUES AT, MELO AA, MORENO PRH, ENE LL,HENRIQUES JAP AND SCHAPOVAL EES. 1996. Erva tamia coronaria: Chemical constituents and some pharmacological activities. J Ethnopharmacol 50: 19–25.

HOSTETTMANN K, BORLOZ A, URBAIN A AND MARSTON A. 2006. Natural product inhibitors of acetylcholinesterase. Curr Org Chem 10: 825–847.

HOUGHTON PJ, REN YH AND HOWES MJ. 2006. Acetylcholinesterase inhibitors from plants and fungi. Nat Prod Rep 23: 181–199.

INGKANINAN K, CHANGWIJIT K AND SUWANBORIRUX K. 2006. Vobasinyl-iboga bisindole alkaloids, potent acetylcholinesterase inhibitors from Tabernaemontana divaricata root. J Pharm Pharmacol 58: 847–852.

JI HF AND ZHANG HY. 2006. Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimer's disease. J Mol Struct – Theochem 767: 3–9.

KATO L, BRAGA RM, KOCH I AND KINOSHITA LS. 2002. Indole alkaloids from Rauvolfia bahiensis ADC (Apocynaceae). Phytochemistry 60: 315–320.

LEMOS TLG, ANDRADE CHS, GUIMARÃES AM, WOLTER W AND BRAZ-FILHO R. 1996. 19-Epivoacristine, an iboga alkaloid isolated from Peschiera affinis. J BrazChem Soc 7: 123–126.

MARQUES MFS, KATO L, LEITÃO HF AND REIS F. 1996. Indole alkaloids from Aspidosperma ramiflorum. Phytochemistry 41: 963–967.

MEDEIROS WLB, VIEIRA IJC, MATHIAS L, BRAZ-FILHO R,LEALKZ, RODRIGUEZ E AND SCHRIPSEMAJ. 1999. Two known bis-indole alkaloids isolated from Tabernaemontana laeta: complete H-1 and C-13 chemical shift assignments. Magn Reson Chem 37: 676–681.

MEDEIROS WLB, VIEIRA IJC, MATHIAS L, BRAZ-FILHO R AND SCHRIPSEMA J. 2001. A new natural quaternary indole alkaloid isolated from Tabernaemontana laeta Mart. (Apocynaceae). J Braz Chem Soc 12: 368–372.

MONNERAT C, DE SOUZA JJ, MATHIAS L, BRAZ-FILHO R AND VIEIRA IJC. 2005. A new indole alkaloid isolated from Tabernaemontana hystrix Steud (Apocynaceae). J Braz Chem Soc 16: 1331–1335.

MROUE MA, EULER KL, GHUMAN MA AND ALAN M. 1996. Indole alkaloids of Haplophyton crooksii. J NatProd 59: 890–893.

MUKHERJEE PK, KUMAR V, MAL M AND HOUGHTON PJ.2007. Acetylcholinesterase inhibitors from plants. Phytomedicine 14: 289–300.

PEREIRA CG, MARQUES MOM, BARRETO AS, SIANI AC,FERNANDES EC AND MEIRELES MAA. 2004. Extraction of indole alkaloids from Tabernaemontana catharinensis using supercritical CO2 plus ethanol: an evaluation of the process variables and the raw material origin. J Supercrit Fluids 30: 51–61.

RATTMANN YD, TERLUK MR, SOUZA WM, SANTOS CAM, BIAVATTI M, TORRES LBH, MESIA-VELA S,RIECK L, DA SILVA-SANTOS JE AND MARQUES MCD. 2005. Effects of alkaloids of Himatanthus lancifolius (Muell. Arg.) Woodson, Apocynaceae, on smooth muscle responsiveness. J Ethnopharmacol 100: 268–275.

RHEE IK, VAN DER MEENT M, INGKANINAN K AND VERPOORTE R. 2001. Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. J Chromatogr A 915: 217–223.

RHEE IK, VAN RIJN RM AND VERPOORTE R. 2003. Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. Phytochem Anal 14: 127–131.

SAXTON JE. 1997. Recent progress in the chemistry of the monoterpenoid indole alkaloids. Nat Prod Rep 14: 559–590.

ZOCOLER MA, DE OLIVEIRA AJB, SARRAGIOTTO MH,GRZESIUK VL AND VIDOTTI GJ. 2005. Qualitative determination of indole alkaloids of Tabernaemontana fuchsiaefolia (Apocynaceae). J Braz Chem Soc 16: 1372– 1377.

Manuscript received on September 12, 2007; accepted for publication on March 17, 2008; contributed by ANGELO C. PINTO* * Member Academia Brasileira de Ciências and RAIMUNDO BRAZ-FILHO* * Member Academia Brasileira de Ciências

  • ANDRADE MT, LIMA JA, PINTO AC, REZENDE CM, CARVALHO MP AND EPIFANIO R DE A. 2005. Indole alkaloids from Tabernaemontana australis (Muell. Arg) Miers that inhibit acetylcholinesterase enzyme. BioorgMed Chem 13: 40924095.
  • BATINA MD, CINTRA ACO, VERONESE ELG, LAVRADOR MAS, GIGLIO JR, PEREIRA PS, DIAS DA, FRANCA SC AND SAMPAIO SV. 2000. Inhibition of the lethal and myotoxic activities of Crotalus durissus terrificus venom by Tabernaemontana catharinensis: Identification of one BATof the active components. Planta Med 66: 424428.
  • BATISTA CVF, SCHRIPSEMA J, VERPOORTE R, RECH SB AND HENRIQUES AT. 1996. Indole alkaloids from Rauwolfia sellowii Phytochemistry 41: 969973.
  • BOLZANI VS, DA ROCHA AI AND GOTTLIEB OR. 1984. Plant chemosystematics and phylogeny. 23. Indole alkaloids as systematic markers of the Apocynaceae. Biochem Syst Ecol 12: 159166.
  • CARDOSO CAL AND VILEGAS W. 1999. Droplet countercurrent chromatography of indole alkaloids from Tabernaemontana hilariana Phytochem Anal 10: 6063.
  • CARDOSO CAL, VILEGAS W AND POZETTI GL. 1997. Gas chromatographic analysis of indole alkaloids from Tabernaemontana hilariana J Chromatogr A 788: 204206.
  • CARDOSO CAL, VILEGAS W AND HONDA NK. 1998. Qualitative determination of indole alkaloids, triterpenoids and steroid of Tabernaemontana hilariana J Chromatogr A 808: 264268.
  • CARDOSO CAL, CASTRO-GAMBOA I, SILVA DHS, FURLAN M, EPIFANIO R DE A, PINTO AC, REZENDE CM,LIMA JA AND BOLZANI VS. 2004. Indole glucoalkaloids from Chimarrhis turbinate and their evaluation as antioxidant agents and acetylcholinesterase inhibitors. J Nat Prod 67: 18821885.
  • CHATTIPAKORN S, PONGPANPARADORN A, PRATCHAYASAKUL W, PONGCHAIDACHA A, INGKANINAN K AND CHATTIPAKORN N. 2007. Tabernaemontana divaricata extract inhibits neuronal acetylcholinesterase activity in rats. J Ethnopharmacol 110: 6168.
  • FARLOW M. 2002. A clinical overview of cholinesterase inhibitors in Alzheimer's disease. Int Psychogeriatr 14: 93126.
  • GOEDERT M AND SPILLANTINI MG. 2006. A century of Alzheimer's disease. Science 314: 777781.
  • HENRIQUES AT, MELO AA, MORENO PRH, ENE LL,HENRIQUES JAP AND SCHAPOVAL EES. 1996. Erva tamia coronaria: Chemical constituents and some pharmacological activities. J Ethnopharmacol 50: 1925.
  • HOSTETTMANN K, BORLOZ A, URBAIN A AND MARSTON A. 2006. Natural product inhibitors of acetylcholinesterase. Curr Org Chem 10: 825847.
  • HOUGHTON PJ, REN YH AND HOWES MJ. 2006. Acetylcholinesterase inhibitors from plants and fungi. Nat Prod Rep 23: 181199.
  • INGKANINAN K, CHANGWIJIT K AND SUWANBORIRUX K. 2006. Vobasinyl-iboga bisindole alkaloids, potent acetylcholinesterase inhibitors from Tabernaemontana divaricata root. J Pharm Pharmacol 58: 847852.
  • JI HF AND ZHANG HY. 2006. Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimer's disease. J Mol Struct Theochem 767: 39.
  • KATO L, BRAGA RM, KOCH I AND KINOSHITA LS. 2002. Indole alkaloids from Rauvolfia bahiensis ADC (Apocynaceae). Phytochemistry 60: 315320.
  • LEMOS TLG, ANDRADE CHS, GUIMARÃES AM, WOLTER W AND BRAZ-FILHO R. 1996. 19-Epivoacristine, an iboga alkaloid isolated from Peschiera affinis J BrazChem Soc 7: 123126.
  • MARQUES MFS, KATO L, LEITÃO HF AND REIS F. 1996. Indole alkaloids from Aspidosperma ramiflorum Phytochemistry 41: 963967.
  • MEDEIROS WLB, VIEIRA IJC, MATHIAS L, BRAZ-FILHO R,LEALKZ, RODRIGUEZ E AND SCHRIPSEMAJ. 1999. Two known bis-indole alkaloids isolated from Tabernaemontana laeta: complete H-1 and C-13 chemical shift assignments. Magn Reson Chem 37: 676681.
  • MEDEIROS WLB, VIEIRA IJC, MATHIAS L, BRAZ-FILHO R AND SCHRIPSEMA J. 2001. A new natural quaternary indole alkaloid isolated from Tabernaemontana laeta Mart. (Apocynaceae). J Braz Chem Soc 12: 368372.
  • MONNERAT C, DE SOUZA JJ, MATHIAS L, BRAZ-FILHO R AND VIEIRA IJC. 2005. A new indole alkaloid isolated from Tabernaemontana hystrix Steud (Apocynaceae). J Braz Chem Soc 16: 13311335.
  • MROUE MA, EULER KL, GHUMAN MA AND ALAN M. 1996. Indole alkaloids of Haplophyton crooksii J NatProd 59: 890893.
  • MUKHERJEE PK, KUMAR V, MAL M AND HOUGHTON PJ.2007. Acetylcholinesterase inhibitors from plants. Phytomedicine 14: 289300.
  • PEREIRA CG, MARQUES MOM, BARRETO AS, SIANI AC,FERNANDES EC AND MEIRELES MAA. 2004. Extraction of indole alkaloids from Tabernaemontana catharinensis using supercritical CO2 plus ethanol: an evaluation of the process variables and the raw material origin. J Supercrit Fluids 30: 5161.
  • RATTMANN YD, TERLUK MR, SOUZA WM, SANTOS CAM, BIAVATTI M, TORRES LBH, MESIA-VELA S,RIECK L, DA SILVA-SANTOS JE AND MARQUES MCD. 2005. Effects of alkaloids of Himatanthus lancifolius (Muell. Arg.) Woodson, Apocynaceae, on smooth muscle responsiveness. J Ethnopharmacol 100: 268275.
  • RHEE IK, VAN DER MEENT M, INGKANINAN K AND VERPOORTE R. 2001. Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining. J Chromatogr A 915: 217223.
  • RHEE IK, VAN RIJN RM AND VERPOORTE R. 2003. Qualitative determination of false-positive effects in the acetylcholinesterase assay using thin layer chromatography. Phytochem Anal 14: 127131.
  • SAXTON JE. 1997. Recent progress in the chemistry of the monoterpenoid indole alkaloids. Nat Prod Rep 14: 559590.
  • ZOCOLER MA, DE OLIVEIRA AJB, SARRAGIOTTO MH,GRZESIUK VL AND VIDOTTI GJ. 2005. Qualitative determination of indole alkaloids of Tabernaemontana fuchsiaefolia (Apocynaceae). J Braz Chem Soc 16: 1372 1377.
  • Correspondence to:
    Rosângela de A . Epifanio
    E-mail:
  • *
    Member Academia Brasileira de Ciências
  • Publication Dates

    • Publication in this collection
      05 Sept 2008
    • Date of issue
      Sept 2008

    History

    • Received
      12 Sept 2007
    • Accepted
      17 Mar 2008
    Academia Brasileira de Ciências Rua Anfilófio de Carvalho, 29, 3º andar, 20030-060 Rio de Janeiro RJ Brasil, Tel: +55 21 3907-8100 - Rio de Janeiro - RJ - Brazil
    E-mail: aabc@abc.org.br